Ronn E Mcdaniel, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 128 2nd St Nw, Ortonville, MN 56278 Phone: 320-839-3413 |
Dr. Christopher J Conroy, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 217 3rd Street Nw, Ortonville, MN 56278 Phone: 320-839-2608 Fax: 320-839-2601 |
Conroy Eye Care, Pa Optometrist Medicare: Medicare Enrolled Practice Location: 217 3rd St Nw, Ortonville, MN 56278 Phone: 320-839-2608 Fax: 320-839-2601 |
Ortonville Family Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 128 2nd St Nw, Ortonville, MN 56278 Phone: 320-839-3413 |
Dr Ronn Mcdaniel Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 128 2nd St Nw, Ortonville, MN 56278 Phone: 320-839-3413 |
News Archive
Insure.com, Inc. (Nasdaq: NSUR), announced today that it has completed its corporate name change to Life Quotes, Inc. The Company also announced that its Nasdaq ticker symbol will be changed to QUOT effective with the opening of the market on October 28, 2009.
Genentech, Inc., a wholly owned member of the Roche Group, and Biogen Idec announced today the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab) in combination with fludarabine and cyclophosphamide (FC) for people with previously untreated and previously treated CD20-positive chronic lymphocytic leukemia (CLL).
A new study has shown that some brain cells actually slow down if a person has not got adequate sleep at night. This leads to periods of mental lapses. Researchers of University of California, Los Angeles (UCLA) and Tel Aviv University have proven this in their published study that appeared in the journal Nature Medicine online this Monday (6th of November 2017).
The Royal College of Speech and Language Therapists has partnered with Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc., to publish their journal International Journal of Language and Communication Disorders (IJLCD), starting in 2011.
The Centre for Brain Research at the MedUni Vienna is regarded as a world leader in researching the mechanisms involved with multiple sclerosis (MS). Now, in a paper published in the highly respected journal Lancet Neurology, an international team of researchers from Edinburgh, Cleveland and Vienna, under the leadership of Hans Lassmann, Head of the Department of Neuroimmunology at the MedUni Vienna, has for the first time documented the pathological progress of the disease from its early to late stage and also shown that inflammatory and neurodegenerative processes have a role to play.
› Verified 4 days ago